African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 7, July 2025 | pp. 353–360

DOI: 10.46882/AJIDR/148814

Article Type: Clinical Study

Title: Seroepidemiology and clinical outcomes of Lassa fever virus infection among febrile patients presenting to secondary healthcare facilities

Names of Authors: Ibrahim Turay¹*, Sophie Laurent², Kenji Takahashi³

Authors’ Affiliations: ¹Department of Community Health, College of Medicine and Allied Health Sciences, Freetown, Sierra Leone. ²Emerging Pathogens Unit, Pasteur Institute, Paris, France. ³Department of Virology, Nagasaki University, Nagasaki, Japan.

Abstract: Lassa fever is an acute viral hemorrhagic illness endemic to West Africa that frequently mimics common tropical febrile syndromes. This prospective study determined Lassa virus seroprevalence, clinical predictors, and case fatality rates among acute febrile admissions. Serum samples from 390 patients were tested for anti-Lassa IgM and IgG antibodies via enzyme-linked immunosorbent assay and viral RNA via reverse transcription polymerase chain reaction. Acute Lassa infection was confirmed in 14.1 percent of patients, with mucosal bleeding, elevated liver transaminases, and acute kidney injury independently associated with mortality. Early intravenous ribavirin therapy improved survival rates. Strengthening peripheral diagnostic capacity is vital for timely clinical management.

Keywords: Lassa fever, Viral hemorrhagic fever, Arenavirus, Ribavirin, Febrile illness

Citation: Turay I, Laurent S, Takahashi K (2025). Seroepidemiology and clinical outcomes of Lassa fever virus infection among febrile patients presenting to secondary healthcare facilities. African Journal of Infectious Diseases Research, 12(7): 353–360. DOI: 10.46882/AJIDR/148814

Manuscript Timeline: Received: May 25, 2025; Revised: June 25, 2025; Accepted: July 06, 2025; Published: July 14, 2025